These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Gout: a comprehensive review. Rymal E; Rizzolo D JAAPA; 2014 Sep; 27(9):26-31. PubMed ID: 25102078 [TBL] [Abstract][Full Text] [Related]
28. [A case of fulminant hepatitis, possibly caused by benzbromarone]. Suzuki T; Suzuki T; Kimura M; Shinoda M; Fujita T; Miyake N; Yamamoto S; Tashiro K Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):421-5. PubMed ID: 11400273 [No Abstract] [Full Text] [Related]
29. Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone). Day R; Lee H; Graham G; Williams K N Z Med J; 2013 Sep; 126(1382):124-6. PubMed ID: 24154781 [No Abstract] [Full Text] [Related]
30. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Lee MH; Graham GG; Williams KM; Day RO Drug Saf; 2008; 31(8):643-65. PubMed ID: 18636784 [TBL] [Abstract][Full Text] [Related]
31. Benzbromarone in the treatment of gout. Azevedo VF; Kos IA; Vargas-Santos AB; da Rocha Castelar Pinheiro G; Dos Santos Paiva E Adv Rheumatol; 2019 Aug; 59(1):37. PubMed ID: 31391099 [TBL] [Abstract][Full Text] [Related]
32. International position paper on the appropriate use of uricosurics with the introduction of lesinurad. Jansen TL; Perez-Ruiz F; Tausche AK; Richette P Clin Rheumatol; 2018 Dec; 37(12):3159-3165. PubMed ID: 30244431 [TBL] [Abstract][Full Text] [Related]
33. [Management of hyperuricemia in diabetes]. Hirai A; Saito Y Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564 [No Abstract] [Full Text] [Related] [Previous] [New Search]